HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[An experimental study of coronary arteriosclerosis after heart transplantation].

Abstract
The purpose of this study is to evaluate the effects of Cyclosporine (CsA), FK-506 (FK) and 15-Deoxyspergualin (DOS) on coronary arteriosclerosis after rat heart transplantation. Three groups of Lewis rats (n = 7, each) received heterotopic heart transplants from F-344 donors and were treated with CsA (Group Cs), FK (Group FK) and DOS (Group DOS) intraperitoneally. All rats were sacrificed 60 days later and assessed microscopic grading score (GS) of rejection and arteriosclerosis, and measured serum lipid. There was no significant difference in the GS of rejection but the GS of arteriosclerosis in the groups Cs was significantly higher than the group DOS (1.71 +/- 0.24 versus 1.11 +/- 0.34, p < 0.01). Triglyceride in the groups Cs was significantly higher than the group FK and group DOS (99 +/- 23 versus 66 +/- 21, 56 +/- 30 mg/dl, p < 0.02), and LDL in the group Cs and group FK was significantly higher than group DOS (104 +/- 17, 81 +/- 23 versus 31 +/- 17 mg/dl, p < 0.01). We concluded that DOS had a superior protective effect against coronary arteriosclerosis after heart transplantation and it may depend on the different mechanism of immunosuppression and lipid metabolism abnormality causing by immunosuppressants.
AuthorsS Nagamine
Journal[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai (Nihon Kyobu Geka Gakkai Zasshi) Vol. 41 Issue 10 Pg. 2040-8 (Oct 1993) ISSN: 0369-4739 [Print] Japan
PMID8228407 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Lipids
  • Cyclosporine
Topics
  • Animals
  • Coronary Artery Disease (blood, chemically induced)
  • Cyclosporine (adverse effects)
  • Graft Rejection
  • Heart Transplantation
  • Immunosuppressive Agents (adverse effects)
  • Lipids (blood)
  • Male
  • Rats
  • Rats, Inbred F344
  • Rats, Inbred Lew

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: